LDH highlights opioid‑death decline and seeks CMS waiver for Medicaid reentry program

Louisiana Department of Health officials addressed judges with a broad leadership update focused on behavioral health, opioid response, and Medicaid initiatives. LDH reported a recent 31% decline in opioid overdose deaths and emphasized expanded Narcan distribution and community response capabilities.

In addition to prevention work, LDH described a pending Medicaid waiver application to the federal Center for Medicare & Medicaid Services that staff said would allow trial reentry supports in a set of correctional facilities and jails. Officials said the waiver — if approved — would enable treatment continuity, medication availability (including MAT), and coordinated community referrals for people leaving incarceration.

"This last measurement here, we've recently done for opioid overdose deaths by 31 percent," an LDH official said, noting Narcan distribution and local provider partnerships. The agency indicated CMS award decisions could come within weeks and that pilot sites would be chosen to test health‑system interventions tied to Medicaid matching and community treatment continuity.

LDH also described work on a comprehensive statewide behavioral‑health strategy and additional investments in crisis response and community‑level resources that the department says are intended to reduce inappropriate hospitalizations and 'warehousing' of youth.

Why it matters: A Medicaid waiver that permits reentry treatment and continuity of care could reshuffle how correctional health care, Medicaid eligibility, and community treatment are coordinated, with potential implications for both public health outcomes and criminal justice supervision.